Elevance Health Inc.’s (ELV) brand, Anthem Blue Cross and Blue Shield, recently entered into a multi-year deal with the Georgia-based integrated healthcare system, Piedmont. The agreement, effective from the very beginning of April 2024, serves as a sign of the continued collaboration between the ELV brand and Piedmont. This, in turn, is expected to equip the partners in continuing to offer high quality care services to the mutually served 400,000-plus members residing across metro Atlanta, Athens, Augusta, ...

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to ...

公司盈利预期 - Elevance Health (ELV) 属于医疗服务行业，过去两个季度一直超过盈利预期[2] - 在最近一个季度，Elevance Health 的盈利预期为每股5.55美元，实际报告为每股5.62美元，超出预期1.26%[3] - 公司的盈利预期一直呈上升趋势，部分原因是过去的盈利惊喜[4] - 公司目前的盈利预期为+0.74%，分析师对其近期盈利潜力持乐观态度[8] - 公司的盈利预期与Zacks Rank 2 (Buy)相结合，显示可能会再次超出预期[8] 盈利预期分析 - 负的盈利预期并不代表盈利不达预期，但负值会降低该指标的预测能力[9] - 公司的盈利预期对于季度发布前的检查非常重要，可以增加成功的几率[11]

美国股市 - 美国股市在过去15个月中经历了惊人的涨势，主要受全球人工智能（AI）的繁荣推动，特别是生成式AI[1] - 高估值的股票让许多金融研究人员和分析师对投资持怀疑态度，尽管这些公司的短期业务前景仍然良好[2] 市场趋势 - 市场参与者更多地转向周期性行业，如工业、金融、能源、材料和交通运输等，导致华尔街的牛市变得更加广泛[3]

KEY TAKEAWAYS Grocery-store chain Kroger is selling its specialty pharmacy business to U.S. health insurer Elevance Health. Kroger didn’t disclose financial details of the deal, which it said is expected to close in the second half of 2024. The deal comes after the Federal Trade Commission last month sued to block the merger between Kroger and Albertsons. Grocery-store chain Kroger (KR) is selling its specialty pharmacy business to U.S. health insurer Elevance Health (ELV). Kroger didn’t disclose the financ ...

Grocery store operator The Kroger Company plans to sell its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health. Kroger has entered into a definitive agreement for the sale, the company said in a Monday (March 18) press release. Subject to customary closing conditions and regulatory approvals, the sale is expected to close in the second half. “As part of our regular review of assets, it became clear that our strong specialty pharmacy business unit will better meet its full potential ou ...

Elevance Health, Inc. (ELV) is strategically poised for growth, driven by increasing memberships in individual commercial risk-based businesses and Blue Card businesses. Improving performance in the Carelon Services business is a significant tailwind for the company. Elevance, with a market capitalization of $118.6 billion, is a major health benefits company in the United States. Due to solid prospects, this currently Zacks Rank #2 (Buy) stock is worth investing in at the moment. In this analysis, we'll exp ...

Elevance Health (ELV) closed the latest trading day at $510.57, indicating a +0.21% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.29% for the day. Meanwhile, the Dow experienced a drop of 0.35%, and the technology-dominated Nasdaq saw a decrease of 0.3%. The health insurer's stock has climbed by 0.67% in the past month, falling short of the Medical sector's gain of 3.72% and the S&P 500's gain of 4.42%. The investment community will be closely monitorin ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these Wall Street heavyweights have to say about Elevance Health (ELV) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. Elevance Health currently has an average brokerage reco ...

公司收购 - Elevance Health, Inc. 完成了对 Paragon Healthcare, Inc. 的收购，以提升其在多地点输液服务和专科药房方面的能力[1] - 通过将 Paragon Healthcare 整合到其 CarelonRx 药房服务部门，ELV有望降低护理成本，为患者提供更多输液药物选择[3] Paragon Healthcare 网络 - Paragon Healthcare 在八个州拥有广泛的门诊输液中心和家庭输液药房网络，为超过35,000名患者提供生命拯救和生命赋予疗法[5]